IAP-IAP Complexes Required for Apoptosis Resistance of C. trachomatis–Infected Cells by Rajalingam, Krishnaraj et al.
IAP-IAP Complexes Required for Apoptosis











1 Department of Molecular Biology, Max Planck Institute for Infection Biology, Berlin, Germany, 2 Biochemistry/Protein Purification Core Facility, Max Planck Institute for
Infection Biology, Berlin, Germany
Host cells infected with obligate intracellular bacteria Chlamydia trachomatis are profoundly resistant to diverse
apoptotic stimuli. The molecular mechanisms underlying the block in apoptotic signaling of infected cells is not well
understood. Here we investigated the molecular mechanism by which apoptosis induced via the tumor necrosis factor
(TNF) receptor is prevented in infected epithelial cells. Infection with C. trachomatis leads to the up-regulation of
cellular inhibitor of apoptosis (cIAP)-2, and interfering with cIAP-2 up-regulation sensitized infected cells for TNF-
induced apoptosis. Interestingly, besides cIAP-2, cIAP-1 and X-linked IAP, although not differentially regulated by
infection, are required to maintain apoptosis resistance in infected cells. We detected that IAPs are constitutively
organized in heteromeric complexes and small interfering RNA–mediated silencing of one of these IAPs affects the
stability of another IAP. In particular, the stability of cIAP-2 is modulated by the presence of X-linked IAP and their
interaction is stabilized in infected cells. Our observations suggest that IAPs are functional and stable as heteromers, a
thus far undiscovered mechanism of IAP regulation and its role in modulation of apoptosis.
Citation: Rajalingam K, Sharma M, Paland N, Hurwitz R, Thieck O, et al. (2006) IAP-IAP complexes required for apoptosis resistance of C. trachomatis–infected cells. PLoS
Pathog 2(10): e114. DOI: 10.1371/journal.ppat.0020114
Introduction
The modulation of host cell apoptosis appears to be an
important mechanism for many bacterial pathogens in
order to establish an infection. Certain pathogens like
Salmonella spp., Shigellae spp., and Yersiniae spp. induce
apoptosis of macrophages to avoid eradication by profes-
sional phagocytes, the ﬁrst line of defense of the immune
system [1,2]. However, experimental data derived from
infections in caspase-1 knockout mice demonstrate that
host cell apoptosis as a consequence of bacterial infection
may also serve as a defense strategy of the host [3]. In this
context, it is important to note that pathogenic bacteria
have also evolved strategies to efﬁciently prevent host cell
apoptosis. Bacteria of this group may depend on the intact
host cell not only to complete their life cycle but also to
protect themselves from the host immune system like in the
case of the obligate intracellular Rickettsia spp. and Chlamydia
spp. [4–7].
Whereas some of the mechanisms underlying bacteria-
induced apoptosis are established [8], relatively little is
known about how bacterial infection actively interferes with
host cell apoptosis. The study of cell culture models has
gained more insights into possible principles of infection-
induced apoptosis inhibition, which might also be relevant
in vivo. One of these ﬁndings is that infection of host cells
by obligate intracellular bacteria like Rickettsia rickettsii might
initially start the intrinsic cell death program but is then
counteracted by bacteria-induced antiapoptotic nuclear
factor-jB (NF-jB) activation [5]. In addition to inhibition
of apoptosis triggered as a consequence of infection,
induction of apoptosis by external stimuli may also be
prevented. Cells infected with Chlamydia trachomatis (Ctr) or
C. pneumoniae resist receptor-, stress-, and granzyme B–
induced apoptosis [4,6,7]. These ﬁndings suggested that
inhibition of apoptosis may play a role in maintaining the
integrity of the infected cell by resisting these cytotoxic T-
cell responses.
Caspases, the executioners of the apoptotic program [9],
are activated either by stimulation of surface-exposed death
receptors [10] or by mitochondria, which respond to
apoptosis triggers with the release of caspase-activating
factors [11]. Caspases are synthesized as zymogens with low
enzymatic activity. Initiator caspase-8 is activated upon
ligation of death receptors by recruitment to the death
inducing signaling complex [12], while caspase-9 activation is
mediated by the formation of the apoptosome via mitochon-
drial pathways [11]. These initiator caspases cleave and
activate the effector caspases, for example, caspase-3 and
caspase-7.
The activation of effector caspases is considered to be a
point of no return in apoptotic signaling and controlled at
multiple levels [12–15]. Inhibitors of apoptosis protein (IAPs)
constitute an important class of apoptosis regulators func-
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baculovirus IAP repeat (BIR) and the RING domain. The BIR
domains are essential for the antiapoptotic function of IAPs
and are involved in the direct binding to caspases [13,16].
Some of the IAPs have been shown to contain ubiquitin
transferase activity, which is associated with the C-terminal
RING domain of these proteins. However, not all of the eight
human IAP members identiﬁed so far contain a RING
domain and their potency to prevent apoptosis also differs
signiﬁcantly [13]. In the case of X-linked IAP (XIAP), the
RING domain contains E3 ligase activity involved in
autoubiquitination but also in the ubiquitination of caspases
[17].
Regulation of IAPs seems to involve different mechanisms
and pathways. The proapoptotic Smac/DIABLO, an IAP-
interacting and -inactivating protein, is released from the
mitochondria together with cytochrome c [18,19]. Omi/
HtrA2, another mitochondrial protein released during the
onset of apoptosis, is a serine protease which inactivates IAPs
by cleavage [20]. Some of the IAPs, like cellular inhibitor of
apoptosis-2 (cIAP-2) and XIAP, are transcriptionally up-
regulated by the antiapoptotic NF-jB [21]. However, the
mechanisms underlying IAP regulation are still poorly
understood.
Here we show that inhibition of apoptosis in cells infected
with Ctr depends on cIAP-1, cIAP-2, and XIAP. Infection
induced the up-regulation of cIAP-2, and the recruitment
and stabilization of other IAPs leading to apoptosis
resistance. Apart from cIAP-2 silencing, blocking the
expression of cIAP-1 and XIAP also sensitized Ctr-infected
cells to apoptosis induced by TNF receptor. In addition,
depletion of IAPs affected the stability of other IAPs. We
have detected that IAPs are constitutively organized in
several heteromeric complexes and function in concert in
regulating the stability of each other and the survival of the
cell. In particular, we have detected cIAP-1, cIAP-2, and
XIAP in a constitutive high-molecular-weight complex of
around 400 kDa at endogenous levels in the HeLa cell
cytosol, suggesting the presence of a constitutive IAP-IAP
complex and revealing a thus far undiscovered mechanism
of IAP regulation.
Results
Processing of Caspase-3 Is Blocked in Infected Cells
Chlamydia-infected cells exhibit an extensive resistance to
various stimuli of the extrinsic and intrinsic apoptotic
pathways [4,6,7]. It has been shown previously that apoptosis
is blocked at the level of Bak and Bax activation in Ctr-
infected cells [22,23]. However, apoptosis is efﬁciently
induced via the TNF receptor in mouse embryonic ﬁbroblast
and in HeLa cells lacking Bak and Bax [24] (Oliver Kepp, K.
Rajalingam, and T. Rudel, unpublished data), suggesting that
TNF-induced apoptosis is independent of these mitochon-
drial effectors. To unravel the molecular basis for resistance
of infected cells for TNF-induced apoptosis [6], the activation
of caspases was investigated in detail. Caspase-3 is cleaved at
aspartic acid residue D175 generating the small subunit and
the p19 N-terminal fragment containing the prodomain. The
prodomain is then cleaved autocatalytically to generate the
p17 fragment indicative of fully active caspase-3 [25]. Stand-
ard caspase-3 blots revealed that activation of caspases is
blocked at the level of caspase-3 as the processing of the p19
fragment of caspase-3 to the active p17 fragment is ablated in
the infected cells treated with TNF and cycloheximide (CHX)
(Figure 1A). However, Chlamydia infection did not block the
activation of caspase-8 as the full-length caspase is processed
into the mature p18 fragment and the caspase-8 substrate
BID is similarly processed in the control and in the infected
cells treated with TNF/CHX (Figure 1B). In addition, we made
use of Biotin-VAD-fmk to detect active caspases present in
treated and infected cells. Biotin-VAD-fmk binds to active
caspase dimers in an irreversible manner and facilitates their
precipitation using streptavidin resin. Infected and non-
infected HeLa cells were treated with TNF/CHX and active
caspases were precipitated with Biotin-VAD-fmk. To avoid
the nonspeciﬁc degradation of host cell proteins observed in
lysates of infected cells (unpublished data), a special protocol
for sample preparation was used (see Protocol S1) and the
amount of caspases in lysates of infected cells was always
controlled (Figure 1C and 1D). Precipitates were then
separated and tested by immunoblot analysis for the presence
of active caspase-8 and caspase-3. Initiator caspase-8 was
present in reduced amounts in the precipitate of infected
cells (Figure 1D), suggesting only a partial activation in
infected cells. The partial activation of caspase-8 was veriﬁed
by a second assay that exploits the activation-dependent
binding of ﬂuorescently labeled substrates which can then be
quantiﬁed under a ﬂuorescent microscope (Figures 1E and
S1; for details, see Protocol S1). Consistent with the previous
observations, caspase-3 was not detected in biotin-VAD-fmk
precipitates (Figure 1D), suggesting that effector caspase-3
downstream of caspase-8 is not activated in infected cells.
Further, to evaluate the effects of infection time and
apoptosis induction time on chlamydial inhibition of
caspase-3, activation time-course experiments were per-
formed. These analyses revealed that the appearance of the
active p17 fragment of caspase-3 decreased with time post-
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Synopsis
Apoptosis is a kind of programmed cell death that plays a crucial
role in normal development and homeostasis. Pathogens modulate
host cell apoptosis to establish a successful infection. Chlamydia
trachomatis (Ctr) are obligate intracellular bacteria that are shown to
be a major causative of sexually transmitted diseases in humans.
Here the authors unveil the molecular mechanisms behind
resistance to apoptosis in the infected cells. They suggest that Ctr-
mediated apoptosis resistance requires a special group of proteins
called inhibitors of apoptosis protein (IAP). IAPs block the very last
step in the apoptotic pathway by preventing the activation of
effector proteases (caspases) responsible for killing the cells.
Although Ctr infection leads to the up-regulation of one of the
IAPs, cellular inhibitor of apoptosis (cIAP)-2, X-linked IAP (XIAP), and
cIAP-1 are still required to maintain apoptosis resistance. These data
suggested that IAPs work in unison to modulate cell survival. In
addition, the authors identified that IAP proteins are constitutively
organized into heteromeric complexes in tumor cells to modulate
their stability and cell survival. In particular, the authors detected
that cIAP-1, cIAP-2, and XIAP exist in a high-molecular-weight
‘‘IAPosome’’ complex, which interacts with caspases to resist
apoptosis. These observations thus enhance our current under-
standing of Chlamydia–host interaction as well as IAPs, which are
targeted by cancer therapeutics.infection irrespective of the time of apoptosis induction
(Figure 1F). As expected, caspase-8 processing was not altered
at later time points postinfection, suggesting that caspase-8 is
activated in the infected cells (Figure 1G).
Transcriptional and Posttranscriptional Regulation of IAPs
in Infected Cells
The lack of active effector caspase-3 in infected cells
indicated that Ctr infection may prevent caspase activation
by IAPs, which inhibit caspases by direct binding and/or the
Figure 1. Reduced Activation of Caspase-3 in Infected Cells
(A) HeLa cells were infected (þ) for 16 h or not ( ) and treated for an additional 8 h with TNFa and CHX. Lysates of these cells were separated and
probed with an antibody specifically recognizing the active p19/17 fragment of caspase-3 by immunoblot analysis.
(B) Blots from the same lysates used in (A) were probed for caspase-8 (casp-8 p18) and caspase-3 (casp-3 p19/17). The processing of BID as a specific
substrate for caspase-8 is also shown.
(C) HeLa cells were infected and treated with TNF/CHX as mentioned before. Caspase-8 p60 (Casp-8) and 3 p32 (Casp-3) was detected by immunoblot
analysis of the lysates. b-Actin staining was included as equal loading control.
(D) Active caspase-8 and caspase-3 were precipitated from the same lysates as in (A) using Biotin-VAD-fmk, and precipitated proteins were detected
with antibodies for caspase-8 and caspase-3 as indicated.
(E) Active caspase-8 was monitored in living HeLa cells infected with Ctr and treated with TNFa/CHX (TNF) as described in Protocol S1 (Detection of
active caspases). Shown is the mean 6 SD of three experiments.
(F) Caspase-3 p19 and p17 fragments were detected by immunoblotting in lysates of cells infected for the indicated times with Ctr and treated for 5 or
10 h with TNFa/CHX.
(G) Cells infected for the indicated time points with Ctr were treated with TNFa/CHX for 10 h, and the full-size caspase-8 (p60) and the cleavage
products (p41/43; p18) were analyzed by immunoblotting.
DOI: 10.1371/journal.ppat.0020114.g001
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Infection Blocks Apoptosis by IAP-IAP Complexinduction of their proteasomal degradation [13]. To test
whether chlamydial infection may cause increased expression
of inhibitors of apoptosis, quantitative real-time PCR (qRT-
PCR) was established for mRNA quantiﬁcation of the IAPs.
mRNAs of neither cIAP-1 and XIAP nor survivin were
signiﬁcantly increased in cells infected with Ctr at 24 h
postinfection (Figure 2A). Only the mRNA level of cIAP-2 was
increased 6- to 8-fold (Figure 2A). The expression of IAPs was
also monitored by immunoblot analysis (Figure 2B). The
levels of cIAP-2 and, unexpectedly, that of survivin were
clearly increased in infected cells (Figure 2B). Moreover, time-
course experiments over 48 h revealed a steady increase in
cIAP-2 and survivin protein levels in infected cells (Figure
2C). Since survivin has been shown to play a role in cell cycle
control, up-regulation of survivin could depend on the cell
cycle status of infected cells. FACS analysis, however, revealed
no such difference between infected and noninfected cells
(unpublished data). These data suggested that IAP expression
is controlled by transcriptional and posttranscriptional
mechanisms in infected cells.
IAPs Are Required for Infection-Induced Apoptosis
Resistance
To test if IAPs are required for the inhibition of apoptosis
in infected HeLa cells, small interfering RNAs (siRNAs) were
designed to speciﬁcally interfere with IAP expression.
Silencing of the cIAP-1, cIAP-2, XIAP, and survivin genes was
tested by qRT-PCR (Figure S2A) and immunoblotting (Figure
S2B). Functional siRNAs were then transfected, and infected
and treated cells were analyzed. Interestingly, interfering with
cIAP-2 expression sensitized infected cells to TNF/CHX-
induced apoptosis (Figure 3) as revealed by TUNEL analysis.
We therefore analyzed whether suppression of cIAP-2
expression inﬂuenced the activation of effector caspases.
The generation of the caspase-3 p17 fragment was reduced by
57.8% in infected treated cells compared to treated cells as
was analyzed by densitometry (Figure 3B) suggesting that the
processing of the caspase-3 p19 fragment to the p17 fragment
is controlled by cIAP-2. This assumption is in agreement with
only 28.8% reduction of the p17 fragment in infected treated
cells versus treated cells in which cIAP-2 expression was
reduced by siRNA transfection to the level of noninfected
cells (Figure 3B), demonstrating a 50.17% rescue of p19 to
p17 processing by cIAP-2 silencing.
When the expression of cIAP-1 and XIAP was suppressed
by RNA interference (RNAi), the infected cells were sensitized
to TNF/CHX-induced apoptosis despite the up-regulation of
cIAP-2 (Figure 3C). To conﬁrm these unexpected results, the
same experiment was repeated with a second set of siRNAs to
rule out unspeciﬁc off-target effects of the ﬁrst set of siRNAs
(Figure 3C). It is important to note that irrespective of the cell
type and multiplicity of infection (MOI) used, sensitization
depended on the size of the inclusions. Cells carrying very
large inclusions were resistant to sensitization, suggesting
different mechanisms of apoptosis inhibition during the early
and late phases of infection, respectively (unpublished data).
Sensitization did not correlate with the infection-induced
changes in the expression levels of IAPs since the transfection
of siRNA directed against survivin completely prevented the
strong up-regulation but had no sensitizing effect on TNF/
CHX-induced apoptosis (Figure 3C). These results suggested
that multi-BIR–containing IAPs are involved in apoptosis
resistance of cells infected with Ctr.
IAPs Interact with Each Other
A possible explanation for the sensitization of infected cells
to TNF/CHX-induced apoptosis by silencing of cIAP-1, cIAP-2,
or XIAP was that all IAPs whose ablation sensitized infected
cells are organized in functional complexes. Therefore, we
attempted to isolate endogenous IAP complexes from control
and apoptotic cells. When we precipitated cIAP-2, XIAP was
coprecipitated and vice versa (Figure 4A), suggesting the
interaction of cIAP-2 and XIAP in a complex in these cells.
Figure 2. Infection-Induced Up-regulation of cIAP-2
(A) mRNA levels of different IAPs were monitored by qRT-PCR in HeLa
cells infected (þ) or not ( ) with Ctr. The amount of cIAP-2 mRNA
increases strongly in infected cells.
(B) The level of IAP expression was determined by immunoblot analysis
in noninfected ( ) and infected (þ) cells. Note that cIAP-2 and survivin are
strongly up-regulated in infected cells.
(C) Time course of cIAP-2 and survivin up-regulation was tested in
infected cells by immunoblot analysis. Cells were infected and lysed at
different time points postinfection as indicated.
DOI: 10.1371/journal.ppat.0020114.g002
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probably due to cleavage or degradation during apoptosis
(Figure 4A). Since silencing of cIAP-1 also sensitized infected
cells to apoptosis, we investigated whether cIAP-1 was present
in the cIAP-2–XIAP complex. cIAP-1 was detected in the
cIAP-2–XIAP precipitates by immunoblot analysis (unpub-
lished data) and immunoprecipitates of cIAP-1 contained
cIAP-2 and XIAP (Figure S3), conﬁrming cIAP-1 as part of the
cIAP-2–XIAP complex. Consistent with our sensitization data,
we could not detect survivin in the cIAP-2 and XIAP
immunoprecipitates (Figure S3B). These data also suggested
that the antibodies we used to immunoprecipitate IAPs did
not exhibit cross-reactivity with all BIR domain–containing
proteins. Active caspase-3 was detected in all IAP complexes
Figure 3. IAPs Required for Infection-Induced Apoptosis Resistance
(A) HeLa cells were transfected with control siRNA (siLam) or siIAP-2 and infected (þ Ctr) or not (  Ctr) with Ctr. Then, apoptosis was induced by
treatment with TNF/CHX, and the apoptotic response was measured by phase contrast (PC) and TUNEL analysis. Arrows point to Ctr inclusions.
(B) Infection-induced up-regulation of cIAP-2 prevents the processing of the caspase-3 p19 to the p17 fragment. HeLa cells were transfected with
siRNAs, infected, and treated with TNF/CHX as indicated. cIAP-2 and the p19 and p17 fragment of caspase-3 were monitored by immunoblotting on the
same membrane. The level of cIAP-2 in the siIAP-2 and TNF/CHX-treated infected sample roughly equals that of the uninfected siLuc and TNF/CHX-
treated samples. Note that the proportion of the p19 and p17 fragments in these samples is similar but is clearly shifted in the other TNF/CHX-treated
samples. The proportion of caspase-3 p19 and p17 fragment was calculated by densitometric analysis and outlined below the immunoblot (in %).
(C) The apoptotic response was determined in cells transfected with the indicated siRNAs and either infected (þ) or not ( ) by TUNEL assay. Any one of
the siRNAs directed against cIAP-1, cIAP-2, and XIAP, but not the control and the survivin siRNA, strongly sensitizes infected cells for TNF-induced
apoptosis. Shown is the mean 6 SD of three experiments.
DOI: 10.1371/journal.ppat.0020114.g003
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Infection Blocks Apoptosis by IAP-IAP ComplexFigure 4. IAPs Are Organized in Heteromeric Complexes
(A) Endogenous cIAP-2 and XIAP were immunoprecipitated (IP) from control and apoptotic cells as indicated. The level of endogenous cIAP-2 and XIAP
was determined in precipitates by immunoblotting.
(B) Endogenous IAPs were precipitated from control and TNF/CHX-treated cells and the coprecipitation of active caspase-3 was monitored by
immunoblotting.
(C) Endogenous cIAP-2 was immunoprecipitated from control and infected cells treated or not with TNF/CHX as indicated. The level of endogenous
cIAP-2 and XIAP was determined in precipitates (IP) and in lysates.
(D) The IAP complexes were isolated by gel filtration as mentioned in Materials and Methods. The proteins from different fractions were TCA-
precipitated and resolved in SDS-PAGE, and the presence of IAPs was checked by immunoblot analysis as indicated. Note that high amounts of cIAP-1,
XIAP, and cIAP-2 were present together in a protein complex of around 400 kDa. Shown are the fraction numbers (fractions) and the approximate size
of proteins and complexes in the respective fractions in kDa.
(E) The cytosol from HeLa cells induced to apoptosis with TNF/CHX was isolated by subcellular fractionation, and gel filtration was performed as
mentioned in Materials and Methods. The proteins were separated by SDS-PAGE, and the immunoblot analyses were performed as before.
(F) Gel filtration experiments were performed in XIAP-silenced cells and the presence of cIAP-1 and cIAP-2 in various fractions was tested by
immunoblot analysis. Shown in (C), (D), and (E) are the data from one representative experiment.
DOI: 10.1371/journal.ppat.0020114.g004
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Infection Blocks Apoptosis by IAP-IAP Complexprecipitated from apoptotic cells, indicating a role of these
IAPs in the activation of caspase-3 (Figure 4B). These data
suggested that the ‘‘sensitizing’’ IAPs interact with each other
either directly or indirectly in a single or multiple complexes
to modulate cell survival. Interestingly, increasing amounts of
XIAP coprecipitated with endogenous cIAP-2 from infected
cells compared to noninfected cells (Figure 4C). Since XIAP is
not up-regulated in infected cells (Figure 2A and 2B),
coprecipitation of XIAP and cIAP-2 indicated that both were
recruited to the same complex. Thus, the infection-induced
increase in cIAP-2 levels may initiate the recruitment of the
strong caspases inhibitor XIAP to a complex regulating
caspase-3 activity.
IAPs Are Organized in Large Heteromeric Complexes
To prove the existence of native IAP-IAP complexes, we
isolated the cytosol of HeLa cells by subcellular fractionation
and separated the proteins by gel ﬁltration. cIAP-1, cIAP-2,
and XIAP were found together in fractions containing protein
complexes of around 400 kDa, and the fractions representing
the monomeric forms (Figure 4D). While low amounts of
cIAP-2, XIAP, and cIAP-1 were also present in several of the
high-molecular-weight fractions, survivin was mainly detected
in the low-molecular-weight fraction reﬂecting the mono-
meric size (Figure 4D). Similar high-molecular-weight IAP-IAP
complexes could also be detected in the cytosol of HecIB cells
and Jurkat T cells (Figures S4 and S5A). To check if the 400-
kDa complex is disrupted during apoptosis, gel ﬁltration
experiments were performed with HeLa and Jurkat cells
induced to apoptosis with TNF/CHX and anti-CD95 antibody,
respectively (Figures 4E and S5B). Consistent with our
previous observations (Figures 4A and S3), only low amounts
of IAPs were detected in the fractions from apoptotic cells,
suggesting that IAPs are possibly cleaved or degraded during
cell death (Figures 4E and S5B). However, we have also
detected a small amount of cIAP-1 in a high-molecular-weight
fraction of around 850 kDa in HeLa cell fractions, suggesting
that cIAP-1 is possibly recruited to a different complex during
apoptosis. It was already known that Smac binds to IAPs and
inactivates them during apoptosis. To investigate if the
interaction of Smac with the IAP-IAP complex occurs during
apoptosis, we probed the same blots for Smac. Interestingly,
Smac was detected in all the IAP-containing fractions of high
but not of low molecular weight (Figures 4E and S5B),
suggesting an interaction and a possible inactivation of these
IAP complexes by Smac during apoptosis. Similar results were
obtained when these cells were induced to apoptosis with
cisplatin (unpublished data). Consistent with a role of the
heteromeric IAP complex for the activation of caspases,
caspase-3 copuriﬁed with the Smac-enriched fractions in
apoptotic cells (Figures 4E and S5B). This, and the exclusive
presence of Smac and active caspase-3 in the high-molecular-
weight fractions, may suggest that a heteromer rather than a
monomer is probably the functional IAP unit. Taken together,
these data conﬁrmed that ‘‘sensitizing’’ IAPs are organized in
heteromeric complexes.
IAPs Stabilize Each Other
In addition to transcriptional regulation, IAP stability is
posttranslationally controlled by phosphorylation, polyubi-
quitination, and proteasomal degradation [13,26]. As we have
detected IAP-IAP complexes at endogenous levels in these
cells, we tested if loss of individual IAPs inﬂuences the
stability of other IAPs. siRNAs were transfected in HeLa cells
and the amount of IAPs was measured by immunoblot
analysis. The speciﬁcity of the different siRNAs, e.g., the lack
of any cross-inhibition on other IAPs, was conﬁrmed by qRT-
PCR (Figure S6). To avoid potential unspeciﬁc degradation of
host proteins by chlamydial proteases during lysis, infected
cells were resuspended in gel loading buffer on ice followed
by boiling. This procedure preserved host proteins of lysed
infected cells and was used in all experiments. Surprisingly,
silencing of XIAP expression had a pronounced effect on the
amount of up-regulated cIAP-2 and survivin in infected cells
(Figure 5). Down-regulation of cIAP-2 led to a mild reduction
of cIAP-1 and survivin but had no inﬂuence on XIAP levels.
However, suppression of cIAP-1 expression had no negative
effect on cIAP-2 or XIAP, and repression of survivin by RNAi
did not alter cIAP-1, cIAP-2, or XIAP levels (Figure 5),
suggesting that some of the ‘‘sensitizing’’ IAPs exert a
stabilizing activity on other IAPs. All these data suggested
that IAPs can inﬂuence the stability of each other.
Among the ‘‘sensitizing’’ IAPs, the most evident observa-
tion was the regulation of IAP-2 stability by XIAP. To
understand the possible mechanisms, we have established the
permanent silencing of XIAP by lentiviral transfer of shRNA
(shXIAP) into HeLa cells. Chlamydial infection induced the
up-regulation of cIAP-2 mRNA levels in vector control and
shXIAP-transduced cells (unpublished data). To check if the
loss of XIAP disrupts the formation of the IAP-IAP complex,
we performed gel ﬁltration experiments with the cytosol of
XIAP-silenced cells. Immnunoblot analysis revealed that
cIAP-1 and most of the cIAP-2 were no longer detected in
the 400-kDa fractions of XIAP-silenced cells (Figure 4). In
addition, a portion of cIAP-2 was consistently present in the
high-molecular-weight fraction of around 1 to 1.5 MDa,
suggesting that cIAP-2 is recruited to a different complex in
the absence of XIAP (Figure 4). As cIAP-2 has an inherent
destructive capability by autoubiquitination and proteasome-
mediated degradation [27], we checked if the loss of the
infection-induced up-regulated fraction of cIAP-2 can be
rescued by pretreatment of these cells with proteasome
inhibitors. As expected, infection of the control (empty
vector-carrying) cells leads to an increase in cIAP-2 protein
levels. Consistent with the previous observations, we could
not detect the up-regulated fraction of cIAP-2 in the infected
cells expressing shXIAP (Figure S7A). When the cells were
treated with proteasome inhibitors, the up-regulated fraction
of cIAP-2 was indeed rescued in the infected XIAP-silenced
cells (Figure S7A). Since proteins are degraded not only in the
proteasomes but also in the lysosomes [28], we checked if the
turnover of cIAP-2 protein levels in these cells is also
inﬂuenced by the degradation by lysosomes. Surprisingly,
pretreatment of cells with the lysosomal H
þ-ATPase inhibitor
Baﬁlomycin also inhibited the degradation of cIAP-2 in the
control and XIAP-silenced cells in a similar fashion (Figure
S7A), suggesting that the degradation of cIAP-2 in these cells
is mediated by both proteasomes and lysosmes. To investigate
whether cIAP-2 overexpressed by transfection of a eukaryotic
expression vector behaves similarly to cIAP-2 up-regulated
during infection, cIAP-2 was transfected into XIAP-silenced
cells and treated with proteasome and lysosome inhibitors.
The inhibitors failed to prominently increase the amounts of
cIAP-2 in transfected control and XIAP-silenced cells (Figure
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Infection Blocks Apoptosis by IAP-IAP ComplexS7B). Interestingly, cIAP-2 transfected control cells contained
reduced amounts of XIAP, which was partially rescued by
proteasomal inhibitor MG132 (Figure S7B). These data
showed that, different than in infection-induced up-regula-
tion, overexpression of transfected cIAP-2 could not be
rescued by either proteasomal or lysosomal inhibitors but
rather caused the proteasomal degradation of endogenous
XIAP.
Discussion
Many obligate intracellular bacteria have been shown to
actively inhibit apoptosis in their host. However, functional
data on the molecular mechanisms underlying the apoptosis
block in infected cells are rare. We show here that the activity
and stability of IAPs are regulated by chlamydial infection
causing resistance to TNF/CHX-induced apoptosis. We
demonstrate here the existence of large heteromeric native
IAP complexes involved in the control of caspase activation.
HeLa cells infected with Ctr resisted TNF/CHX-induced
apoptosis in an IAP-dependent fashion. A possible explan-
ation for the marked apoptosis resistance observed in
infected cells was therefore the infection-induced up-regu-
lation of cIAP-2 speciﬁcally blocking the activation of
effector caspase-3. Although cIAP-1 and cIAP-2 are also part
of the TNF-receptor complex potentially modulating the
activity of caspase-8 [29,30], a direct inhibition of caspase-8
activity by IAPs has not been demonstrated yet. We found the
levels of active caspase-8 slightly reduced in infected cells.
The caspase-8 substrate BID was, however, cleaved as
efﬁciently as in noninfected cells, suggesting the effector
caspases as major targets for apoptosis inhibition by IAPs. We
have detected increased amounts of coprecipitating XIAP in
the cIAP-2 immunoprecipitates from the infected cells. Since
XIAP has been found to tether mature caspase-3 to the
apoptosome and release of caspase-3 required the XIAP-
antagonizing protein Smac [31], the IAP complex formed in
cells infected with Ctr may thus favor the association of IAPs
and recruitment of caspase-3 in a way refractory to
activation. Consistent with this, neither cytochrome c nor
Smac is released from the mitochondria of infected cells
(unpublished data), although BID is similarly processed in the
infected and control cells treated with TNF/CHX, suggesting
that chlamydial infection employs multiple strategies to resist
host cell apoptosis.
Mammalian IAPs have been reported to form homodimers
and heterodimers, which raises the possibility that they can
cross-regulate each other. It was shown that cIAP-1
 /  cells
have increased levels of cIAP-2 protein consistent with the
down-regulation of cIAP-2 by cIAP-1 [32]. Silke et al. [33]
demonstrated a direct interaction of XIAP with overex-
pressed cIAP-1 via their RING domains to modulate the
stability of XIAP in melanoma cells. In addition, it was shown
that in response to cell death stimuli, survivin associated with
XIAP via the BIR domain to promote the stability of XIAP
[34]. Apoptosis resistance of infected cells required cIAP-2
up-regulation but also XIAP and cIAP-1, as depletion of the
Figure 5. IAPs Cross-Regulate Each Other
siRNAs directed against (A) luciferase or XIAP, (B) cIAP-1, (C) cIAP-2, or (D) survivin were transfected in HeLa cells, and the protein levels of all IAPs were
determined in infected (þ) or uninfected ( ) samples by immunoblot analysis as indicated.
DOI: 10.1371/journal.ppat.0020114.g005
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regulation. The most likely explanation was therefore that all
these IAPs are organized in a functional complex. We could
indeed conﬁrm the direct association of cIAP-1, cIAP-2, and
XIAP in these cells by immunoprecipitation and gel ﬁltration
experiments, suggesting that they function in unison to
modulate the activation of caspases in vivo. We found no
effect of survivin on apoptosis of infected cells, although
survivin-depleted cells underwent mitotic catastrophe and
formed giant cells (unpublished data) as previously described
[35], suggesting that the depletion by RNAi was effective.
Consistent with this, although survivin is stabilized in the
infected cells, loss of survivin did not inﬂuence the resistance
of Chlamydia-infected cells to cell death (Figure 3C).
By applying gel ﬁltration assays,we could demonstrate the
existence of a high-molecular-weight heteromeric complex in
the range of 400 kDa containing cIAP-1, cIAP-2, and XIAP.
However, we have also detected IAPs in other high-
molecular-fractions, suggesting the existence of several IAP-
containing complexes. In support of our sensitization data,
we could not detect survivin in the IAP-containing high-
molecular-weight fractions.
Since depletion of XIAP by siRNAs affected the stability of
cIAP-2 (Figure 5A), we asked whether loss of XIAP led to
disintegration of IAP complexes. Gel ﬁltration experiments
with XIAP-silenced cells revealed that this is indeed the case
as cIAP-1 was detected only in the monomeric fractions.
However, apart from the monomeric fractions and trace
amounts in the 400-kDa fractions, a signiﬁcant portion of
cIAP-2 was also found in a high-molecular-weight fraction of
around 1 MDa, which may reﬂect the recruitment to a
different complex possibly involved in the fate of cIAP-2
under these conditions. These results are in contrast to what
was reported from XIAP knockout MEFs which contained
larger amounts of cIAP-1 and cIAP-2 than wild-type MEFs
[36]. Besides species-speciﬁc differences, it may also reﬂect
differences between the knockdown and knockout condi-
tions.
If IAPs are organized into stable complexes, what is their
role during apoptosis? Several studies have demonstrated that
all the IAPs can bind to caspases directly to inhibit cell death.
However, we found a direct role only for cIAP-1, cIAP-2, and
XIAP in maintaining apoptosis resistance under these
conditions. Silencing any one of the IAPs removes the
blockade in the processing of caspase-3 to the active p17
fragment in response to TNF/CHX in infected cells (Figure 3B
and unpublished data). Therefore, it is tempting to speculate
that a heteromeric IAP-IAP complex is more potent to block
caspases than individual IAPs in vivo.
As we have detected IAPs in heteromeric complexes, we
addressed the question if Smac directly associates with these
complexes during apoptosis. Interestingly, gel ﬁltration
experiments with apoptotic cells revealed the presence of
Smac and active caspase-3 in all the IAP-containing high-
molecular-weight fractions, irrespective of the apoptosis
inducer, suggesting that Smac indeed binds and inactivates
IAP-IAP complexes in vivo to induce effector caspase
activation and cell death.
The role of ubiquitination in sorting the proteins for
proteasomes and lysosomes is well established. While poly-
ubiquitination of substrates frequently leads to the degrada-
tion of proteins by the proteasome, monoubiquitination or
multimonoubiquitination (one ubiquitin on several lysine
residues within the substrates) could target the substrate for a
different subcellular compartment like the lysosomes [28].
Here we revealed that cIAP-2 levels in the infected cells are
regulated by both lysosomes and proteasomes. Treatment of
the cells with proteasome and, surprisingly, with lysosomal
inhibitors could rescue cIAP-2 in control and XIAP-silenced
cells suggesting different ubiquitin modiﬁcations in cIAP-2.
However, when we overexpressed cIAP-2 by transfection of
expression constructs, we could not rescue XIAP, in the
presence of neither MG132 nor Baﬁlomycin (Figure S7B).
Consistent with results described by Silke et al. (2005),
overexpression of cIAP-2 by transfection caused the degra-
dation of endogenous XIAP (Figure S7B). Because we did not
observe degradation of XIAP in infected cells with high cIAP-
2 levels, it suggests that Chlamydia infection interferes with
this process, or that NF-jB targets other factors, which
inﬂuence relative stabilities of IAPs. Loss of cIAP-1 has also
been described to result in the increase of cIAP-2 but not
XIAP [32]. While we did not observe these effects in our
siRNA experiments, it appears that a general theme of
posttranscriptional regulation by IAPs among themselves is
emerging.
We are currently investigating the effect of overexpressed
IAPs on the native IAP complexes demonstrated here. Taken
together, our data of a constitutive ‘‘IAPosome,’’ where IAPs
positively affect the stability of other IAPs important for their
apoptosis-inhibiting activity, are a new aspect of how these
proteins function. Considering the already visible levels of
complexity, it will be an intriguing task to unravel the
functional interplay of these fascinating apoptosis regulators.
Moreover, cIAP-2 is not only involved in antiapoptosis
induced by Ctr in epithelial cells but is also up-regulated in
monocytes infected with C. pneumoniae [37] and plays an
important role in the apoptosis resistance of epithelial cells
infected with C. pneumoniae [38]. Pathogenic bacteria and
viruses known to stimulate antiapoptotic activities in their
host cells induce the up-regulation of cIAP-2 [39–41],
suggesting that the mechanism proposed here has general
relevance for the host–pathogen interaction.
Materials and Methods
Cell culture and growth of Ctr. HeLa, HEp-2, HecIB, and Jurkat
cells were cultured in RPMI-1640 medium supplemented with 10%
fetal calf serum (GIBCO-BRL, San Diego, California, United States)
and penicillin (100 U/ml)/streptomycin (100 lg/ml) (GIBCO-BRL) at
37 8C in 5.0% CO2. C. trachomatis LGV serovar L2 was routinely
propagated in the human laryngeal epithelial HEp-2 cells (ATCC
[American Type Culture Collection, Manassas, Virginia, United
States] CCL23) grown in cell growth medium (CGM), which consists
of RPMI medium supplemented with 2 mM glutamine, 25 mM
HEPES, 10% (vol/vol) FBS, and 10 lg of gentamicin/ml. Stock
organisms were prepared essentially as described previously [42,43]
and stored at  75 8C. Fresh stocks were used for each experiment.
Transfection of siRNAs and subsequent infection. To inhibit
expression of genes with siRNAs, 50,000 cells/well were seeded in a 12-
well plate at least 20 h prior to transfection. siRNAs designed for the
inhibition of the genes under investigation and for Lamin A/C
(siLam) or luciferase (siLuc) as negative control were transfected
using the Transmessenger transfection kit or the RNAiFect kit
(Qiagen, Valencia, California, United States). One day post trans-
fection, the nearly conﬂuent cells were trypsinized and seeded out in
12-well plates with glass coverslips or in six-well plates. The cells were
then infected with Ctr at an MOI of 5 at 36 to 40 h post transfection,
and 24 h later, the samples were analyzed by Western blot or induced
to apoptosis. The following siRNAs were used in this study. siLuc:
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GUUCAGUG, siIAP-1 [2] CUAGGAGACAGUCCUAUUCAA, siIAP-
2: AAUUGGGAACCGAAGGAUAAU, siIAP-2 [2]: TTCAAGAUACA-
CAGUUUCUAA, siXIAP: AAGUGCUUUCACUGUGGAGGA, siXIAP
[2]: AACGAGAGAUUUGGAAAGATA, siSurv: AAGCAUUCGUCCG-
GUUGCGCU, siSurv [2]: UGCACCACUUCCAGGGUUUAU, siLamin
A/C: AA CUGGACUUCCAGAAGAACA.
Permanent silencing of XIAP by shRNAs. HeLa cells stably
expressing the XIAP shRNAs were generated according to http://
www.tronolab.com. Brieﬂy, 293T cells were transfected by the calcium
phosphate method with the target vectors pLVTH-M–shXIAP and
viral packaging vectors. After 48 h, lentiviral supernatants were
ﬁltered through a 0.45-lm ﬁlter and concentrated by ultracentrifu-
gation at 106,7503g, and infections of HeLa cells were performed in
the presence of polybrene (Sigma, St. Louis, Missouri, United States).
At 8 h postinfection, medium was exchanged, and after 48 h, GFP-
positive cells were enriched by FACS (FACSDiva; Becton-Dickinson,
Palo Alto, California, United States). The knockdown efﬁciency of the
shRNA was quantiﬁed by immunoblotting and qRT-PCR analysis.
Single-cell clones of shXIAP-expressing cells were isolated by FACS
analysis, and the efﬁciency of the knockdown was quantiﬁed by qRT-
PCR (see Protocol S1). The clone with the best knockdown efﬁciency
was then expanded and used for various experiments. HeLa cells
transduced with the empty vector were used as a control.
SDS-PAGE and Western blot. For SDS-PAGE, cells were lysed in
single detergent buffer (20 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1%
NP-40, 1 lg/ml aprotinin, 0.5 lg/ml leupeptin, 1 mM Pefabloc
[Pentapharm Ltd.], 10 lM pepstatin) for 15 to 20 min on ice and
sonicated twice for 15 s. Lysates were cleared by centrifugation for 10
min at 13,000 rpm. Sample buffer (3% 2-mercaptoenthanol, 20%
glycerin, 0,05% bromphenol blue, and 3% SDS) was added to these
lysates and boiled at 90 8C for 2 min before loading onto the gels.
However, in most of the experiments, cells were directly lysed with
the sample buffer. The lysed cells were collected and loaded onto
SDS-PAGE after heating the lysates to 90 8C for 5 min. After
separation, the proteins were transferred to PVDF membranes. For
immunoblot analysis, membranes were blocked with 3% BSA in TBS
with 0.5% Tween-20 for 2 h and incubated with antibodies directed
against b-actin (Sigma), active anti-caspase-3 antibody (Cell Signaling
Technology, Beverly, Massachusetts, United States), caspase-9 (Up-
state, Millipore, Billerica, Massachusetts, United States), caspase-10
(Santa Cruz Biotechnology, Santa Cruz, California, United States),
cIAP-1 mouse monoclonal antibody (PharMingen, San Diego,
California, United States), cIAP-2 mouse monoclonal antibody
(PharMingen), anti-XIAP mouse monoclonal anibody, survivin (Santa
Cruz Biotechnology), or Lamin A/C (Chemicon, Temecula, California,
United States). Antigen–antibody complexes were detected by
horseradish peroxidase–coupled antibodies (PharMingen) followed
by enhanced chemiluminescence (New England Biolabs, Beverly,
Massachusetts, United States). To check for the presence of several
IAPs in the immunoprecipitation experiments, the True Blot system
from eBioscience (San Diego, California, United States) was used to
avoid cross-reaction of the antibody heavy and light chains with the
secondary antibody.
The rescue experiments with proteasomal and lysosomal inhibitors
were performed as follows. Control and XIAP-silenced cells were
infected at an MOI of 3 and treated with 5 nM Baﬁlomycin
(Calbiochem, San Diego, California, United States) or 10 lM MG132
(Calbiochem) for 5 to 6 h. The cells were lysed and immunoblot
analyses were performed. In case of transfection experiments, 1 lgo f
cIAP-2 was transfected into control and XIAP-silenced cells using
LipofectAMINE (Invitrogen, Carlsbad, California, United States)
following the manufacturer’s instructions.
Immunoprecipitation. To check for the organization of IAPs in
complexes, we established a single-step immunoprecipitation proto-
col. Infected and noninfected HeLa cells grown in 10-cm tissue
culture dishes were treated with TNF/CHX as mentioned above. Cells
were lysed with phosphate lysis buffer (100 mM NaCl, 10 mM
NaHPO4, 2 mM EGTA, 1 mM EDTA, 10 mM NaF, 10 mM Na2P2O7,
0.5% sodium deoxycholate, 0.05% SDS, 5% glycerol, and 1% NP-40)
with complete protease inhibitor cocktails on ice. The cells were
collected by scraping the cells from the surface using a plastic rubber
policeman and then sonicated for a few seconds to lyse the cells. All
subsequent steps were performed in the cold room to avoid the
nonspeciﬁc degradation of the host cell proteins by chlamydial
proteases at room temperature. The immunoprecipitations were
performed using antibodies against mouse monoclonal antibodies
against cIAP-2, XIAP, and cIAP-1 (PharMingen) or survivin (Santa
Cruz Biotechnology) overnight at 4 8C in an overhead rotator.
Antigen–antibody complexes were then collected by protein A/G
slurry for 2 h and washed with IP buffer before adding sample buffer.
Samples were subjected to Western blot analysis using the True Blot
system (eBioscience) following the manufacturer’s instructions.
Subcellular fractionation. HeLa cells were cultured in 150-cm
2
ﬂasks and harvested using a rubber policeman. Apoptosis was
induced with TNF/CHX as described in Protocol S1, and the
apoptotic cells were enriched by repeated washing with PBS. The
cells were collected by centrifugation for 5 min at 3403g at 4 8C. The
pellet was washed with PBS and then resuspended in MB buffer (400
mM Sucrose, 50 mM Tris, 1 mM EGTA, 5 mM b-mercaptoethanol, 10
mM KH2PO4 [pH 7.6]). The suspension was kept on ice for 20 min,
and the cells were then disrupted with a Dounce homogenizer. The
nuclei and cell debris were removed by centrifugation at 1,0753g for
2 min. The supernatant was centrifuged again at 10,000 rpm for 10
min to remove the mitochondria. The resulting supernatant was used
as the cytosolic fraction to perform gel ﬁltration experiments.
Gel ﬁltration chromatography. The mitochondria-free cytosol
fraction was applied to a Superdex 200 HR 26/60 column (Amersham
Pharmacia,LittleChalfont,UnitedKingdom)ataﬂowrateof1ml/min.
The column was equilibrated with PBS, and 5-ml fractions were
collectedstartingat80ml(columnvoidvolumeis100ml).Thefractions
weremixedwithanequalvolumeof25% trichloroacetic acidandkept
on ice for 30 min. Precipitated proteins were collected at 3,7753g for
30 min. The pellet was washed twice with acetone and dissolved in SDS
sample buffer for analysis by SDS-PAGE and immunoblotting.
Supporting Information
Figure S1. Caspase-8 Is Active in Infected Cells
Active caspase-8 was monitored in living HeLa cells infected with Ctr
and treated with TNFa/CHX (TNF) as described in Protocol S1
(Detection of active caspases). Shown are immunoﬂuorescence and
phase contrast images of representative ﬁelds. Note the increase in
ﬂuorescing cells irrespective of an intact cell layer in the infected
treated sample.
Found at DOI: 10.1371/journal.ppat.0020114.sg001 (93 KB PPT).
Figure S2. siRNAs Reduce the mRNA and Protein Levels of IAPs
(A) siRNAs directed against different IAPs strongly reduce the
respective mRNA as was measured by qRT-PCR (see Protocol S1).
(B) Lysates of siRNA transfected and control cells either infected (þ)
or not ( ) were analyzed by immunblotting for the amount of the
respective IAP protein as indicated. Equal loading was controlled by
staining with anti–b-actin antibody.
Found at DOI: 10.1371/journal.ppat.0020114.sg002 (300 KB PPT).
Figure S3. IAPs Interact with Each Other
(A) Endogenous cIAP-1 was immunoprecipitated from control and
apoptotic cells as mentioned in Materials and Methods. The copreci-
pitating cIAP-2 and XIAP were checked by immunoblot analysis.
(B) survivin is not present in the cIAP-2 and XIAP IPs. The cIAP-2 and
XIAP IPs were probed for survivin by immunoblotting. The whole-cell
lysate (WCL) was loaded as a control.
Found at DOI: 10.1371/journal.ppat.0020114.sg003 (876 KB PPT).
Figure S4. IAPs Are Organized in Heteromeric Complexes in HecIB
Cells
The IAP complexes were isolated by gel ﬁltration and detected by
immunoblotting as described in Materials and Methods.
Found at DOI: 10.1371/journal.ppat.0020114.sg004 (1.7 MB PPT).
Figure S5. IAPs Are Organized in Heteromeric Complexes in Jurkat T
Cells
(A) The IAP complexes were isolated by gel ﬁltration and detected by
immunoblotting as described in Materials and Methods.
(B) The cytosol from Jurkat T cells induced to apoptosis with CD95
was isolated by subcellular fractionation and gel ﬁltration was
performed as mentioned in Materials and Methods. The proteins
were separated by SDS-PAGE, and the immunoblot analyses were
performed as before.
Found at DOI: 10.1371/journal.ppat.0020114.sg005 (2.4 MB PPT).
Figure S6. No Cross-Silencing of IAP Genes by Transfection of
siRNAs
siRNAs directed against different IAPs and siLuc were transfected
and mRNA levels of cIAP-1 (A), cIAP-2 (B), XIAP (C), and survivin (D)
were measured by qRT-PCR in control ( ) and infected (þ) cells.
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bars represent 6SD of the mean.
Found at DOI: 10.1371/journal.ppat.0020114.sg006 (67 KB PPT).
Figure S7. Degradation of cIAP-2 Is Mediated by Proteasomes and
Lysosomes
(A) Control and shXIAP-expressing cells were infected with Ctr at an
MOI of 3 for 16 h and treated with either 5 nM Baﬁlomycin and/or 10
lM MG132 for 6 h. The cells were lysed as mentioned in Materials and
Methods, and the levels of XIAP and cIAP-2 were monitored by
immunoblot analysis. Densitometric analysis revealed an increase of
30% of cIAP-2 levels in the infected control compared to the infected
XIAP-depleted cells.
(B) Control and XIAP-silenced cells were transfected with 1 lgo f
pcDNA3 cIAP-2 construct and treated with 10 lM of MG132 for 6 h
before lysis. Levels of cIAP-2 and XIAP were monitored by
immunoblot analysis.
Found at DOI: 10.1371/journal.ppat.0020114.sg007 (293 KB PPT).
Protocol S1. Supplemental Information
Found at DOI: 10.1371/journal.ppat.0020114.sd001 (32 KB DOC).
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